Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
TransMedics to Present at Upcoming March Investor Conferences
-
TD Cowen Reiterates Buy Rating on TransMedics Group (TMDX)
-
TD Cowen Reiterates Buy Rating on TransMedics Group (TMDX)
-
TD Cowen Reiterates Buy Rating on TransMedics Group (TMDX)
-
TransMedics Group (TMDX) PT Raised to $175 at TD Cowen
-
TransMedics Group (TMDX) PT Raised to $130 at TD Cowen
-
TransMedics to Present at Upcoming March Investor Conferences
-
TransMedics to Present at Upcoming March Investor Conferences
-
TransMedics Group (TMDX) Prices Upsized 3.25M Share Offering at $40/sh
-
TransMedics Announces Upsize and Pricing of Public Offering of Common Stock
-
TransMedics Group (TMDX) Announces Proposed $100M Stock Offering
-
TransMedics Announces Proposed Public Offering of Common Stock
-
TransMedics Reports Second Quarter 2022 Financial Results
-
TransMedics Group (TMDX) PT Raised to $39 at Cowen
-
TransMedics Group (TMDX) PT Lowered to $28 at Cowen
-
TransMedics to Present at the Cowen 42nd Annual Healthcare Conference
-
TransMedics Group (TMDX) PT Lowered to $39 at Cowen
-
TransMedics Group (TMDX) Named Best Medical Devices SMidcap Idea - Cowen
-
TransMedics Group (TMDX) PT Raised to $49 at Cowen
-
TransMedics to Present at the Cowen 41st Annual Healthcare Conference
-
TransMedics to Present at the Cowen 40th Annual Health Care Conference
-
TransMedics to Present at the Cowen 40th Annual Health Care Conference
-
Cowen Starts TransMedics Group (TMDX) at Outperform
-
TransMedics Announces Closing of its Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
TransMedics Announces Closing of its Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
TransMedics (TMDX) IPO Opens 27% Higher

